Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2
Abstract Background Hyperoside (quercetin-3-O-β-D-galactopyranoside) is a flavonol glycoside compound derived from plants in the Hypericum and Crataegus genera that reportedly exhibits an array of anti-inflammatory, antioxidant, and antitumor properties such that it has been used to treat various di...
Saved in:
Main Authors: | Junyi Wei (Author), Quanyou Chai (Author), Yuqiao Qin (Author), Long Li (Author), Chunling Guo (Author), Zhaoyang Lu (Author), Huimin Liu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive Analysis of a Ferroptosis Pattern and Associated Prognostic Signature in Acute Myeloid Leukemia
by: Zelong Cui, et al.
Published: (2022) -
Novel targeted therapies in chronic myeloid leukemia
by: Muhammad Sameer Ashaq, et al.
Published: (2024) -
Development and targeted use of nilotinib in chronic myeloid leukemia
by: Carmen Fava, et al.
Published: (2008) -
The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia
by: Andrew Wu, et al.
Published: (2023) -
Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells
by: Xingrong Lai, et al.
Published: (2022)